BioCentury
ARTICLE | Clinical News

Replagal agalsidase alfa enzyme replacement therapy regulatory update

January 8, 2001 8:00 AM UTC

TKTX said the FDA requested additional data for its BLA for Replagal to treat Fabry disease. ...